These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23844569)

  • 1. Impact of the "Diabetes Interactive Diary" telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetes.
    Rossi MC; Nicolucci A; Lucisano G; Pellegrini F; Di Bartolo P; Miselli V; Anichini R; Vespasiani G;
    Diabetes Technol Ther; 2013 Aug; 15(8):670-9. PubMed ID: 23844569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J; Cohen N; Evans M; Hockey A; Speight J; Whately-Smith C
    Diabetes Obes Metab; 2015 Dec; 17(12):1133-41. PubMed ID: 26085028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey.
    Gesuita R; Skrami E; Bonfanti R; Cipriano P; Ferrito L; Frongia P; Iafusco D; Iannilli A; Lombardo F; Mozzillo E; Paleari R; Rabbone I; Sabbion A; Salvatoni A; Scaramuzza A; Schiaffini R; Sulli N; Toni S; Carle F; Cherubini V
    Pediatr Diabetes; 2017 May; 18(3):241-248. PubMed ID: 26990605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine-SORELLA 1 Study.
    Garg SK; Wernicke-Panten K; Rojeski M; Pierre S; Kirchhein Y; Jedynasty K
    Diabetes Technol Ther; 2017 Sep; 19(9):516-526. PubMed ID: 28722480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control by insulin detemir in basal-bolus therapy: treat-to-target study in children and adolescents with type 1 diabetes.
    Nimri R; Lebenthal Y; Shalitin S; Benzaquen H; Demol S; Phillip M
    Pediatr Diabetes; 2013 May; 14(3):196-202. PubMed ID: 23289822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children - randomized controlled trial.
    Ramotowska A; Szypowska A
    Diabetes Metab Res Rev; 2014 Feb; 30(2):146-53. PubMed ID: 24115314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study).
    Vallejo Mora MDR; Carreira M; Anarte MT; Linares F; Olveira G; González Romero S
    Diabetes Technol Ther; 2017 Jul; 19(7):402-409. PubMed ID: 28594575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial.
    Bell KJ; Gray R; Munns D; Petocz P; Steil G; Howard G; Colagiuri S; Brand-Miller JC
    Diabetes Technol Ther; 2016 Apr; 18(4):218-25. PubMed ID: 26840067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension.
    Yki-Järvinen H; Bergenstal RM; Bolli GB; Ziemen M; Wardecki M; Muehlen-Bartmer I; Maroccia M; Riddle MC
    Diabetes Obes Metab; 2015 Dec; 17(12):1142-9. PubMed ID: 26172084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes.
    Tascini G; Berioli MG; Cerquiglini L; Santi E; Mancini G; Rogari F; Toni G; Esposito S
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29361766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.
    Polonsky W; Traylor L; Gao L; Wei W; Ameer B; Stuhr A; Vlajnic A
    J Diabetes Complications; 2017 Mar; 31(3):562-568. PubMed ID: 28040350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
    Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
    Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.
    Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ
    Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA
    Ruiz de Adana MS; Alhambra-Expósito MR; Muñoz-Garach A; Gonzalez-Molero I; Colomo N; Torres-Barea I; Aguilar-Diosdado M; Carral F; Serrano M; Martínez-Brocca MA; Duran A; Palomares R;
    Diabetes Care; 2020 Feb; 43(2):337-342. PubMed ID: 31831473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
    Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec.
    Lecumberri E; Ortega M; Iturregui M; Quesada JA; Vázquez C; Orozco D
    Curr Med Res Opin; 2018 Jun; 34(6):1053-1059. PubMed ID: 29300101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.